Paper41706407
Targeting the Gut Microbiota with Pro- and Postbiotics: Emerging Strategies against Alopecia.
Singh V and 9 others. Probiotics Antimicrob Proteins, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Targeting the Gut Microbiota with Pro- and Postbiotics: Emerging Strategies against Alopecia. Papers, record 41706407. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41706407
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting the Gut Microbiota with Pro- and Postbiotics: Emerging Strategies against Alopecia.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alopecia | Major topic |
| Gastrointestinal Microbiome | Major topic |
| Probiotics | Major topic |
| Prebiotics | Major topic |
| Humans | |
| Animals | |
| Hair Follicle |
Source PubMed
References127
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40850385 | Inpatient management of hidradenitis suppurativa: A single-center retrospective study. | J Am Acad Dermatol | 2026 | https://conductscience.org/library/papers/40850385 | PubMed |
| 2 | 40086468 | The intestinal barrier: a pivotal role in health, inflammation, and cancer. | Lancet Gastroenterol Hepatol | 2025 | https://conductscience.org/library/papers/40086468 | PubMed |
| 3 | 22150070 | Stress-linked cortisol concentrations in hair: what we know and what we need to know. | Rev Neurosci | 2011 | https://conductscience.org/library/papers/22150070 | PubMed |
| 4 | 39942085 | The Role of the Gut Microbiota in Health, Diet, and Disease with a Focus on Obesity. | Foods | 2025 | https://conductscience.org/library/papers/39942085 | PubMed |
| 5 | 39834364 | A comprehensive review of probiotics and human health-current prospective and applications. | Front Microbiol | 2024 | https://conductscience.org/library/papers/39834364 | PubMed |
| 6 | 38570836 | Gut microbiota-derived butyrate restores impaired regulatory T cells in patients with AChR myasthenia gravis via mTOR-mediated autophagy. | Cell Commun Signal | 2024 | https://conductscience.org/library/papers/38570836 | PubMed |
| 7 | 34931698 | A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation. | J Med Virol | 2022 | https://conductscience.org/library/papers/34931698 | PubMed |
| 8 | 38518048 | Mendelian randomization suggests a causal relationship between gut microbiota and nonalcoholic fatty liver disease in humans. | Medicine (Baltimore) | 2024 | https://conductscience.org/library/papers/38518048 | PubMed |
| 9 | 33195367 | Paraprobiotics and Postbiotics of Probiotic Lactobacilli, Their Positive Effects on the Host and Action Mechanisms: A Review. | Front Nutr | 2020 | https://conductscience.org/library/papers/33195367 | PubMed |
| 10 | 27688852 | Beneficial Properties of Probiotics. | Trop Life Sci Res | 2016 | https://conductscience.org/library/papers/27688852 | PubMed |
| 11 | 34196345 | Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice. | Biosci Rep | 2021 | https://conductscience.org/library/papers/34196345 | PubMed |
| 12 | 39070268 | The causal relationship between gut microbiota and alopecia areata: a Mendelian randomization analysis. | Front Microbiol | 2024 | https://conductscience.org/library/papers/39070268 | PubMed |
| 13 | 30857316 | Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications. | Foods | 2019 | https://conductscience.org/library/papers/30857316 | PubMed |
| 14 | 33917707 | Paraprobiotics: A New Perspective for Functional Foods and Nutraceuticals. | Nutrients | 2021 | https://conductscience.org/library/papers/33917707 | PubMed |
| 15 | 40528217 | Fecal microbiota transplantation from patients into animals to establish human microbiota-associated animal models: a scoping review. | J Transl Med | 2025 | https://conductscience.org/library/papers/40528217 | PubMed |
| 16 | 36230169 | Postbiotics: Current Trends in Food and Pharmaceutical Industry. | Foods | 2022 | https://conductscience.org/library/papers/36230169 | PubMed |
| 17 | 30930863 | Probiotics: Reiterating What They Are and What They Are Not. | Front Microbiol | 2019 | https://conductscience.org/library/papers/30930863 | PubMed |
| 18 | 33440387 | The Association between Alopecia and Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. | Dermatology | 2021 | https://conductscience.org/library/papers/33440387 | PubMed |
| 19 | 40647075 | Enteric Delivery of Probiotics: Challenges, Techniques, and Activity Assays. | Foods | 2025 | https://conductscience.org/library/papers/40647075 | PubMed |
| 20 | 35603159 | Airway Administration of Bacterial Lysate OM-85 Protects Mice Against Respiratory Syncytial Virus Infection. | Front Immunol | 2022 | https://conductscience.org/library/papers/35603159 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42857222 | Translating umbilical cord blood extracellular vesicles into a novel therapy for postpartum alopecia: a mechanistic and preclinical review. | Front Immunol | 2026 | https://conductscience.org/library/papers/42857222 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41706407
GET https://conductscience.org/api/papers/v1/41706407/references?page=2